Get started
Author

Austin Stram

Spatial Alignment of Organoids Tracking Subclonal Chemotherapy Resistance in Pancreatic and Ampullary Cancer
2023 · Md Shahadat Hossan, Ethan Samuel Lin, et al. · Bioengineering · 4
PDF
CDK7 is a novel therapeutic target in fibrolamellar carcinoma
2025 · Manabu Nukaya, Patrick R. Carney, et al. · iScience · 2
The DNAJB1–PRKACA Oncogenic Fusion Drives Stepwise Biliary and Pancreatic Carcinogenesis from Intraductal Precursor Lesions
2026 · Patrick R. Carney, Manabu Nukaya, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
Long-read, whole-genome sequencing and chemotherapy response of two patient-derived organoids from a TP53- and KRAS-mutant ovarian carcinoma
2026 · Jae Rim Wendt, Kristin M. Adams, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Abstract 7121: CRISPR druggable-genome screen identifies BRD4 as a synergistic vulnerability with the natural product cerberin in pancreatic cancer organoids
2026 · Md Shahadat Hossan, Lauryn E. Flannagan, et al. · Cancer Research
Abstract 1908: Activity of dual BET and CDK9 inhibition in murine models of pancreatic ductal adenocarcinoma.
2026 · Michela Cadarso, Austin Stram, et al. · Cancer Research
Abstract 4398: Dysregulating transcription and epigenetic remodeling using dual BRD4 and CDK9 inhibition in pancreatic ductal adenocarcinoma
2025 · Lucas J. Koeppel, Austin Stram, et al. · Cancer Research
Abstract 5527: Optimization of CRISPR-Cas9 library screens in pancreatic cancer organoid models targeting KRASG12D
2025 · Md Shahadat Hossan, Lauryn Flannagan, et al. · Cancer Research
Abstract 3019: Targeting transcriptional regulation using CDK7 and CDK9 inhibition as a novel combination therapy in fibrolamellar carcinoma
2025 · Austin Stram, Manabu Nukaya, et al. · Cancer Research
Abstract 7600: Synergy of ZEN3694 and VIP152 for dual transcriptional targeting of BET and CDK9 in patient derived organoid models of pancreatic cancer
2024 · Lucas J. Koeppel, Austin Stram, et al. · Cancer Research
Abstract 220: Thresholding response assessment in biliary tract cancer organoids to inform sensitivity to chemotherapy across molecular subtypes
2024 · Eleanor Riedl, Austin Stram, et al. · Cancer Research
Abstract 305: Bioinspired synthetic hydrogel in pancreatic cancer organoid matrix modeling
2024 · Md Shahadat Hossan, Austin Stram, et al. · Cancer Research
Abstract A071: Pancreas organoid immune co-culture system identifies immunomodulators in pancreas adenocarcinoma
2023 · Johnathan D Ebben, David Turicek, et al. · Molecular Cancer Therapeutics
Abstract A164: Activity of dual BET and CDK9 inhibition in Pancreatic Ductal Adenocarcinoma informed from KinderMiner Prediction
2023 · Austin Stram, Luke Koeppel, et al. · Molecular Cancer Therapeutics
1471 The role of cholesterol handling in gamma delta T cell cytotoxicity against highly immune suppressive pancreas ductal adenocarcinoma
2023 · Johnathan Ebben, David Turicek, et al. · Regular and Young Investigator Award Abstracts
PDF
Abstract 5809: Tracking cancer stem cell expression of pancreatic and ampullary cancer organoids in response to chemotherapy
2023 · Eleanor Riedl, Austin Stram, et al. · Cancer Research
Abstract 3826: Potency of cardiac glycosides by structure in organotypic models of pancreatic and ampullary carcinomas
2023 · Md Shahadat Hossan, Ethan Lin, et al. · Cancer Research
Abstract 5327: Automated organoid alignment for clonal response characterization in pancreatic ductal adenocarcinoma
2023 · Ethan Samuel Lin, Md Shahadat Hossan, et al. · Cancer Research
Abstract A073: Multiplexed therapeutic sensitivity of patient derived pancreatic cancer organoids after neoadjuvant chemotherapy by high content imaging
2022 · Md Shahadat Hossan, Ethan S. Lin, et al. · Cancer Research
Works count: 19
Citation count: 7
H-index: 2
I10-index:
Year
Topic
Type